Advisory Services Network’s Immunovant IMVT Stock Holding History

Advisory Services Network’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$224	Buy	+9	New	+$233	﹤0.01%	4545
2025 Q4	–	Sell	-9	Closed	-$145	–	3027
2025 Q3	$145	Buy	+9	New	+$146	﹤0.01%	4274
2021 Q4	–	Sell	-10,300	Closed	-$90K	–	1453
2021 Q3	$90K	Buy	10,300 +1,300	+14%	+$11.7K	﹤0.01%	1345
2021 Q2	$95K	Buy	+9,000	New	+$126K	﹤0.01%	1641
2021 Q1	–	Sell	-700	Closed	-$32K	–	2118
2020 Q4	$32K	Hold	700	–	–	﹤0.01%	1905
2020 Q3	$25K	Buy	+700	New	+$21.1K	﹤0.01%	1966

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Advisory Services Network's IMVT Position: Q1 2026 in Review

Advisory Services Network opened a new position in Immunovant (IMVT) in Q1 2026: 9 shares worth $224. The stake represents ﹤0.01% of the portfolio and ranks #4545 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in IMVT as recently as Q3 2025.

Advisory Services Network first reported a position in IMVT in Q3 2020 and has held it in 6 quarters since. The position peaked at $95K in Q2 2021. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

Advisory Services Network held 9 shares of Immunovant worth $224 as of Q1 2026.
Immunovant was a new Advisory Services Network position in Q1 2026.
Immunovant made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4545 holding.
Advisory Services Network first reported a position in Immunovant in Q3 2020 and has held it in 6 quarters since.
Advisory Services Network's Immunovant position peaked at $95K in Q2 2021.
215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.